Baseline characteristics of eligible studies evaluating CDH13 methylation and OS or DFS in breast cancer patients.

Authors
Publication date
Publisher
Doi

    Abstract

    <p>Baseline characteristics of eligible studies evaluating CDH13 methylation and OS or DFS in breast cancer patients.</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/33677...
      Last time updated on 12/02/2018